Eleven Biotherapeutics presents data on protein therapeutics for anterior, posterior eye diseases
May 15th 2014During the Association for Research in Vision and Ophthalmology meeting last week, Eleven Biotherapeutics presented data for 2 of its protein therapeutics, which demonstrate the role of cytokine biology to target both anterior and posterior eye diseases.
Study: Wearers of 1-Day Acuvue Moist report low incidence of ocular adverse events
May 12th 2014A year-long study of 1-Day Acuvue TruEye and 1-Day Acuvue Moist brands designed to observe “real-life” contact lens wear found that subjects who wore 1-Day Acuvue Moist reported low incidence of adverse events.
B+L report finds resistance of some ocular pathogens has increased in U.S.
May 12th 2014During the ARVO meeting last week, Bausch + Lomb researchers presented results from the 5th Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study in the United States, as well as the first data from the study in Canada.
Second Sight, Kellogg Eye Center finding early success with artificial retina
May 9th 2014Second Sight Medical Products, Inc. and the University of Michigan Kellogg Eye Center experienced recent success with an artificial retina, which is gaining national attention and giving patients back their sight.
OneSight, SUNY to open vision centers at NYC public schools through Project NYSee
May 6th 2014New York City’s United Federation of Teachers (UFT) and OneSight, a global vision care nonprofit, announce Project NYSee, a new partnership providing New York City public school students with access to vision care.
How ODs and MDs compromised in Nebraska
May 5th 2014The major provisions of two bills introduced in 2013 on behalf of Nebraska Optometric Association (NOA) were combined into LB 526 during the course of the 2014 legislative session. The combined bill would have removed current restrictions on prescribing oral steroids, oral glaucoma agents, and oral immunosuppressives (ODs in NE can prescribe any oral medication except these); authorized specific procedures for treating eyelid cysts; and authorized injections into the eyelid related to those procedures, along with injections for treating anaphylaxis.
Alcon launches new app for ECPs
April 29th 2014Alcon has introduced eye2eye, a new app that features a contact lens finder that helps eyecare professionals identify Alcon contact lens products for their patients and can also help ECPs successfully fit potential multifocal and toric contact lens wearers in less time.